---
figid: PMC7414235__zh30082078190001
figtitle: Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19)
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- unidentified influenza virus
- Middle East respiratory syndrome-related coronavirus
- Vaccinia virus
- Betacoronavirus
- unidentified human coronavirus
- Human coronavirus 229E
- Human coronavirus NL63
- Human coronavirus OC43
- Human coronavirus HKU1
- Glycine max
- Clostridioides difficile
- Scutellaria baicalensis
- Clostridioides difficile CD3
- Clostridioides difficile CD8
- Erigeron breviscapus
- Mus musculus
- Cricetus cricetus
- Homo sapiens
- gut metagenome
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7414235
filename: zh30082078190001.jpg
figlink: pmc/articles/PMC7414235/figure/F0001/
number: F1
caption: 'Mechanism of gastrointestinal symptoms in patients with coronavirus disease
  2019 (COVID-19). ①Gut-lung axis: severe acute respiratory syndrome coronavirus 2
  (SARS-CoV-2) binds with angiotensin-converting enzyme 2 (ACE2) to enter the lung,
  resulting in the accumulation of angiotensin II (ANG II) and the decrease of angiotensin
  (1-7) (Ang1–7). ANG II combined with AT1R promotes cytokine release and increases
  CCR9+CD4+T cells. CCL25 promotes the recruitment of C-C chemokine receptor type
  9 (CCR9)+CD4+T cells into the small intestine. The changed flora then promotes the
  polarization of Th17 cells, and finally IL-17A causes the recruitment of neutrophils.
  Cytokines and bacteria also enter the lung through the bloodstream, further affecting
  the lung inflammation. ②Gut-liver axis: SARS-CoV-2 binds with ACE2 to enter the
  intestine, inhibits the absorption of the B0AT1/ACE2 transport pathway, and then
  affects the activation of mammalian target of rapamycin (mTOR) to reduce the expression
  of antimicrobial peptides. The intestinal flora is transferred to the liver through
  the portal vein, where it binds to toll-like receptors, causing hepatitis. The liver
  also can transport metabolites to the intestine through the biliary tract.'
papertitle: The mechanism and treatment of gastrointestinal symptoms in patients with
  COVID-19.
reftext: Qing Ye, et al. Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G245-G252.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9547318
figid_alias: PMC7414235__F1
figtype: Figure
redirect_from: /figures/PMC7414235__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7414235__zh30082078190001.html
  '@type': Dataset
  description: 'Mechanism of gastrointestinal symptoms in patients with coronavirus
    disease 2019 (COVID-19). ①Gut-lung axis: severe acute respiratory syndrome coronavirus
    2 (SARS-CoV-2) binds with angiotensin-converting enzyme 2 (ACE2) to enter the
    lung, resulting in the accumulation of angiotensin II (ANG II) and the decrease
    of angiotensin (1-7) (Ang1–7). ANG II combined with AT1R promotes cytokine release
    and increases CCR9+CD4+T cells. CCL25 promotes the recruitment of C-C chemokine
    receptor type 9 (CCR9)+CD4+T cells into the small intestine. The changed flora
    then promotes the polarization of Th17 cells, and finally IL-17A causes the recruitment
    of neutrophils. Cytokines and bacteria also enter the lung through the bloodstream,
    further affecting the lung inflammation. ②Gut-liver axis: SARS-CoV-2 binds with
    ACE2 to enter the intestine, inhibits the absorption of the B0AT1/ACE2 transport
    pathway, and then affects the activation of mammalian target of rapamycin (mTOR)
    to reduce the expression of antimicrobial peptides. The intestinal flora is transferred
    to the liver through the portal vein, where it binds to toll-like receptors, causing
    hepatitis. The liver also can transport metabolites to the intestine through the
    biliary tract.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gusb
  - Ace2
  - Agt
  - Ace
  - Mtor
  - Ang3
  - Angpt4
  - Angptl1
  - Angpt1
  - Ang
  - Tm7sf2
  - Ang2
  - Angpt2
  - Ang4
  - Ang5
  - Ang6
  - Cd79a
  - Igha
  - Ccl25
  - Ccr9
  - Ackr2
  - Il17a
  - ACE2
  - ANGPT2
  - VPS51
  - ACE
  - MTOR
  - ANGPTL1
  - ANGPT4
  - ANGPT1
  - TM7SF2
  - ANGPTL3
  - CD79A
  - CCL25
  - CCR9
  - ACKR2
  - IL17A
  - ace2
  - angpt2b
  - ace
  - fgf8a
  - mtor
  - angpt1
  - kita
  - ngfra
  - Amino acid
  - CoV-2
  - Bile acid
  - SARS-CoV-2  SARS-COV-2
---
